CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY
Publication
, Conference
Brown, M; Yang, Y; Mckay, Z; Bigner, D; Ashley, D; Gromeier, M; Nair, S
Published in: NEURO-ONCOLOGY
2022
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
140 / 141
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, M., Yang, Y., Mckay, Z., Bigner, D., Ashley, D., Gromeier, M., & Nair, S. (2022). CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY. In NEURO-ONCOLOGY (Vol. 24, pp. 140–141).
Brown, Michael, Yuanfan Yang, Zachary Mckay, Darell Bigner, David Ashley, Matthias Gromeier, and Smita Nair. “CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY.” In NEURO-ONCOLOGY, 24:140–41, 2022.
Brown M, Yang Y, Mckay Z, Bigner D, Ashley D, Gromeier M, et al. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY. In: NEURO-ONCOLOGY. 2022. p. 140–1.
Brown, Michael, et al. “CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 140–41.
Brown M, Yang Y, Mckay Z, Bigner D, Ashley D, Gromeier M, Nair S. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY. NEURO-ONCOLOGY. 2022. p. 140–141.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
140 / 141
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences